{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:08:52Z","timestamp":1772003332144,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Womens Ment Health"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00737-025-01665-z","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:52:25Z","timestamp":1768287145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trimesters induced changes in pharmacokinetic parameters\u00a0of antipsychotics"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1997-5820","authenticated-orcid":false,"given":"Ida","family":"Adhayanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5522-6785","authenticated-orcid":false,"given":"Robiyanto","family":"Robiyanto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6582-5615","authenticated-orcid":false,"given":"Muh. Akbar","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4602-787X","authenticated-orcid":false,"given":"Elly","family":"Wahyudin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"4","key":"1665_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10928-020-09711-2","volume":"47","author":"K Abduljalil","year":"2020","unstructured":"Abduljalil K, Pansari A, Jamei M (2020) Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: assessing the impact of the longitudinal changes in the activity of CYP1A2, CYP2D6 and CYP3A4 enzymes during pregnancy. J Pharmacokinet Pharmacodyn 47(4):361\u2013383. https:\/\/doi.org\/10.1007\/s10928-020-09711-2","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"10","key":"1665_CR2","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","volume":"44","author":"GD Anderson","year":"2005","unstructured":"Anderson GD (2005) Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 44(10):989\u20131008. https:\/\/doi.org\/10.2165\/00003088-200544100-00001","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"1665_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/jphp.13236","volume":"72","author":"RKS Badhan","year":"2020","unstructured":"Badhan RKS, Macfarlane H (2020) Quetiapine dose optimisation during gestation: a pharmacokinetic modelling study. J Pharm Pharmacol 72(5):670\u2013681. https:\/\/doi.org\/10.1111\/jphp.13236","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"1665_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1124\/dmd.108.023291","volume":"37","author":"GV Bakken","year":"2009","unstructured":"Bakken GV, Rudberg I, Christensen H, Molden E, Refsum H, Hermann M (2009) Metabolism of quetiapine by CYP3A4 and CYP3A5 in presence or absence of cytochrome B5. Drug Metab Dispos 37(2):254\u2013258. https:\/\/doi.org\/10.1124\/dmd.108.023291","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"1665_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/cpt.762","volume":"103","author":"P Bank","year":"2018","unstructured":"Bank P, Caudle K, Swen J, Gammal R, Whirl-Carrillo M, Klein T, Relling M, Guchelaar H (2018) Comparison of the guidelines of the clinical pharmacogenetics implementation consortium and the Dutch pharmacogenetics working group. Clin Pharmacol Ther 103(4):599\u2013618. https:\/\/doi.org\/10.1002\/cpt.762","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"1665_CR6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1176\/ajp.151.6.945","volume":"151","author":"C Barnas","year":"1994","unstructured":"Barnas C, Bergant A, Hummer M, Saria A, Fleischhacker WW (1994) Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk. Am J Psychiatry 151(6):945\u2013945. https:\/\/doi.org\/10.1176\/ajp.151.6.945","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1665_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/01.jcp.0000084028.22282.f2","volume":"23","author":"C Beedham","year":"2003","unstructured":"Beedham C, Miceli JJ, Obach RS (2003) Ziprasidone metabolism, aldehyde oxidase, and clinical implications. J Clin Psychopharmacol 23(3):229\u2013232. https:\/\/doi.org\/10.1097\/01.jcp.0000084028.22282.f2","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"1665_CR8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/bcpt.12960","volume":"122","author":"C Belmonte","year":"2018","unstructured":"Belmonte C, Ochoa D, Rom\u00e1n M, Saiz-Rodr\u00edguez M, Wojnicz A, G\u00f3mez\u2010S\u00e1nchez CI, Mart\u00edn\u2010V\u00edlchez S, Abad\u2010Santos F (2018) Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 polymorphisms on pharmacokinetics and safety of Aripiprazole in healthy volunteers. Basic Clin Pharmacol Toxicol 122(6):596\u2013605. https:\/\/doi.org\/10.1111\/bcpt.12960","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"1665_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/fcp.12967","volume":"38","author":"M Berezowska","year":"2024","unstructured":"Berezowska M, Sharma P, Pilla Reddy V, Coppola P (2024) Physiologically based pharmacokinetic modelling of drugs in pregnancy: a mini-review on availability and limitations. Fundam Clin Pharmacol 38(3):402\u2013409. https:\/\/doi.org\/10.1111\/fcp.12967","journal-title":"Fundam Clin Pharmacol"},{"issue":"5","key":"1665_CR10","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/bcp.13872","volume":"85","author":"C Biesdorf","year":"2019","unstructured":"Biesdorf C, Martins FS, Sy SKB, Diniz A (2019) Physiologically-based pharmacokinetics of ziprasidone in pregnant women. Br J Clin Pharmacol 85(5):914\u2013923. https:\/\/doi.org\/10.1111\/bcp.13872","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1665_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/1389200215666140130124910","volume":"15","author":"K Caudle","year":"2014","unstructured":"Caudle K, Klein T, Hoffman J, Muller D, Whirl-Carrillo M, Gong L, McDonagh E, Sangkuhl K, Thorn C, Schwab M, Agundez J, Freimuth R, Huser V, Michael Lee M, Iwuchukwu O, Crews K, Scott S, Wadelius M, Swen J, Johnson S (2014) Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process. Curr Drug Metab 15(2):209\u2013217. https:\/\/doi.org\/10.2174\/1389200215666140130124910","journal-title":"Curr Drug Metab"},{"issue":"2","key":"1665_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/1933719108329095","volume":"16","author":"JR Challis","year":"2009","unstructured":"Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF, Petraglia F (2009) Inflammation and pregnancy. Reprod Sci 16(2):206\u2013215. https:\/\/doi.org\/10.1177\/1933719108329095","journal-title":"Reprod Sci"},{"key":"1665_CR13","doi-asserted-by":"publisher","unstructured":"Coppola P, Kerwash E, Cole S (2023) Use of physiologically based Pharmacokinetic modeling for hepatically cleared drugs in pregnancy: regulatory perspective. J Clin Pharmacol 63(S1). https:\/\/doi.org\/10.1002\/jcph.2266","DOI":"10.1002\/jcph.2266"},{"issue":"6","key":"1665_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s40262-017-0594-5","volume":"57","author":"A Dallmann","year":"2018","unstructured":"Dallmann A, Ince I, Coboeken K, Eissing T, Hempel G (2018) A physiologically based pharmacokinetic model for pregnant women to predict the pharmacokinetics of drugs metabolized via several enzymatic pathways. Clin Pharmacokinet 57(6):749\u2013768. https:\/\/doi.org\/10.1007\/s40262-017-0594-5","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"1665_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/neurolint14010005","volume":"14","author":"AN Edinoff","year":"2022","unstructured":"Edinoff AN, Sathivadivel N, McNeil SE, Ly AI, Kweon J, Kelkar N, Cornett EM, Kaye AM, Kaye AD (2022) Antipsychotic use in pregnancy: patient mental health challenges, teratogenicity, pregnancy complications, and postnatal risks. Neurol Int 14(1):62\u201374. https:\/\/doi.org\/10.3390\/neurolint14010005","journal-title":"Neurol Int"},{"key":"1665_CR16","doi-asserted-by":"publisher","unstructured":"Eke AC, Gebreyohannes RD, Fernandes MFS, Pillai VC (2023) Physiologic changes during pregnancy and impact on Small-Molecule Drugs, biologic (Monoclonal Antibody) Disposition, and response. J Clin Pharmacol 63(S1). https:\/\/doi.org\/10.1002\/jcph.2227","DOI":"10.1002\/jcph.2227"},{"issue":"5","key":"1665_CR17","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/PL00005298","volume":"358","author":"J Fang","year":"1998","unstructured":"Fang J, Coutts RT, McKenna KF, Baker GB (1998) Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine. Naunyn-Schmiedebergs Arch Pharmacol 358(5):592\u2013599. https:\/\/doi.org\/10.1007\/PL00005298","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"12","key":"1665_CR18","first-page":"1638","volume":"29","author":"J Fang","year":"2001","unstructured":"Fang J, McKay G, Song J, Remillrd A, Li X, Midha K (2001) In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes. Drug Metab Dispos 29(12):1638\u20131643","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"1665_CR19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1161\/01.HYP.0000143849.67254.ca","volume":"44","author":"DJ Freeman","year":"2004","unstructured":"Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, Clark P, Walker ID, Sattar N, Greer IA (2004) Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 44(5):708\u2013714. https:\/\/doi.org\/10.1161\/01.HYP.0000143849.67254.ca","journal-title":"Hypertension"},{"issue":"12","key":"1665_CR20","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1517\/14740338.2014.951325","volume":"13","author":"S Gentile","year":"2014","unstructured":"Gentile S (2014) A safety evaluation of Aripiprazole for treating schizophrenia during pregnancy and puerperium. Exp Opin Drug Saf 13(12):1733\u20131742. https:\/\/doi.org\/10.1517\/14740338.2014.951325","journal-title":"Exp Opin Drug Saf"},{"issue":"3\u20134","key":"1665_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1515\/DMDI.2006.21.3-4.187","volume":"21","author":"J Hasselstr\u00f8m","year":"2006","unstructured":"Hasselstr\u00f8m J, Linnet K (2006) In vitro studies on quetiapine metabolism using the substrate depletion approach with focus on drug-drug interactions. Drug Metab Drug Interact 21(3\u20134):187\u2013212. https:\/\/doi.org\/10.1515\/DMDI.2006.21.3-4.187","journal-title":"Drug Metab Drug Interact"},{"issue":"3","key":"1665_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/0091217415610313","volume":"50","author":"G Hefner","year":"2015","unstructured":"Hefner G, Falter T, Bruns K, Hiemke C (2015) Elevated Risperidone serum concentrations during acute inflammation, two cases. Int J Psychiatry Med 50(3):335\u2013344. https:\/\/doi.org\/10.1177\/0091217415610313","journal-title":"Int J Psychiatry Med"},{"issue":"5","key":"1665_CR23","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00115-020-01006-8","volume":"92","author":"T Hillemacher","year":"2021","unstructured":"Hillemacher T, Simen S, Rehme M-K, Frieling H (2021) Antipsychotika in der schwangerschaft: eine systematische \u00dcbersichtsarbeit. Nervenarzt 92(5):494\u2013500. https:\/\/doi.org\/10.1007\/s00115-020-01006-8","journal-title":"Nervenarzt"},{"issue":"2","key":"1665_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1124\/dmd.112.050245","volume":"41","author":"N Isoherranen","year":"2013","unstructured":"Isoherranen N, Thummel KE (2013) Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes? Drug Metab Dispos 41(2):256\u2013262. https:\/\/doi.org\/10.1124\/dmd.112.050245","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"1665_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13763","volume":"90","author":"MK Jancsura","year":"2023","unstructured":"Jancsura MK, Schmella MJ, Helsabeck N, Gillespie SL, Roberts JM, Conley YP, Hubel CA (2023) Inflammatory markers are elevated in early pregnancy, but not late pregnancy, in women with overweight and obesity that later develop preeclampsia. Am J Reprod Immunol 90(3):e13763. https:\/\/doi.org\/10.1111\/aji.13763","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"1665_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1124\/dmd.31.3.243","volume":"31","author":"AS Kalgutkar","year":"2003","unstructured":"Kalgutkar AS, Taylor TJ, Venkatakrishnan K, Isin EM (2003) Assessment of the contributions of CYP3A4 and CYP3A5 in the metabolism of the antipsychotic agent haloperidol to its potentially neurotoxic pyridinium metabolite and effect of antidepressants on the bioactivation pathway. Drug Metab Dispos 31(3):243\u2013249. https:\/\/doi.org\/10.1124\/dmd.31.3.243","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"1665_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/00498254.2023.2294473","volume":"54","author":"E Kingston","year":"2024","unstructured":"Kingston E, Tingle M, Bellissima BL, Helsby N, Burns K (2024) CYP-catalysed cycling of clozapine and clozapine- N -oxide promotes the generation of reactive oxygen species in vitro. Xenobiotica 54(1):26\u201337. https:\/\/doi.org\/10.1080\/00498254.2023.2294473","journal-title":"Xenobiotica"},{"issue":"6","key":"1665_CR28","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/JCP.0b013e31815a57d8","volume":"27","author":"CM Klier","year":"2007","unstructured":"Klier CM, Mossaheb N, Saria A, Schloegelhofer M, Zernig G (2007) Pharmacokinetics and elimination of Quetiapine, Venlafaxine, and Trazodone during pregnancy and postpartum. J Clin Psychopharmacol 27(6):720\u2013722. https:\/\/doi.org\/10.1097\/JCP.0b013e31815a57d8","journal-title":"J Clin Psychopharmacol"},{"issue":"12","key":"1665_CR29","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s40262-021-01041-x","volume":"60","author":"LA Kneller","year":"2021","unstructured":"Kneller LA, Zubiaur P, Koller D, Abad-Santos F, Hempel G (2021) Influence of CYP2D6 phenotypes on the pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole using a physiologically based pharmacokinetic approach. Clin Pharmacokinet 60(12):1569\u20131582. https:\/\/doi.org\/10.1007\/s40262-021-01041-x","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"1665_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2165\/00003088-199937060-00001","volume":"37","author":"S Kudo","year":"1999","unstructured":"Kudo S, Ishizaki T (1999) Pharmacokinetics of haloperidol: an update. Clin Pharmacokinet 37(6):435\u2013456. https:\/\/doi.org\/10.2165\/00003088-199937060-00001","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"1665_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/bcp.15533","volume":"89","author":"AL Leutritz","year":"2023","unstructured":"Leutritz AL, Van Braam L, Preis K, Gehrmann A, Scherf-Clavel M, Fiedler K, Unterecker S, Kittel\u2010Schneider S (2023) Psychotropic medication in pregnancy and lactation and early development of exposed children. Br J Clin Pharmacol 89(2):737\u2013750. https:\/\/doi.org\/10.1111\/bcp.15533","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"1665_CR32","first-page":"1379","volume":"25","author":"K Linnet","year":"1997","unstructured":"Linnet K, Olesen OV (1997) Metabolism of clozapine by cDNA-expressed human cytochrome P450 enzymes. Drug Metab Dispos 25(12):1379\u20131382","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"1665_CR33","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/cts.13473","volume":"16","author":"WYB Mahdy","year":"2023","unstructured":"Mahdy WYB, Yamamoto K, Ito T, Fujiwara N, Fujioka K, Horai T, Otsuka I, Imafuku H, Omura T, Iijima K, Yano I (2023) Physiologically-based pharmacokinetic model to investigate the effect of pregnancy on Risperidone and Paliperidone pharmacokinetics: application to a pregnant woman and her neonate. Clin Transl Sci 16(4):618\u2013630. https:\/\/doi.org\/10.1111\/cts.13473","journal-title":"Clin Transl Sci"},{"issue":"7","key":"1665_CR34","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.55927\/fjst.v2i7.5186","volume":"2","author":"JA Maulana","year":"2023","unstructured":"Maulana JA, Fatimah J (2023) Physiological changes in mother during pregnancy that impact on the pharmacokinetics and pharmacodynamic of drug: literature review. Formosa Journal of Science and Technology 2(7):1887\u20131900. https:\/\/doi.org\/10.55927\/fjst.v2i7.5186","journal-title":"Formosa Journal of Science and Technology"},{"issue":"4","key":"1665_CR35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1176\/jnp.2008.20.4.485","volume":"20","author":"D Mendhekar","year":"2008","unstructured":"Mendhekar D, Lohia D (2008) Risperidone therapy in two successive pregnancies. J Neuropsychiatry Clin Neurosci 20(4):485\u2013486. https:\/\/doi.org\/10.1176\/jnp.2008.20.4.485","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"1665_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78474-0","volume":"10","author":"\u00c1 Menus","year":"2020","unstructured":"Menus \u00c1, Kiss \u00c1, T\u00f3th K, Sirok D, D\u00e9ri M, Fekete F, Csukly G, Monostory K (2020) Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia. Sci Rep 10(1):21283. https:\/\/doi.org\/10.1038\/s41598-020-78474-0","journal-title":"Sci Rep"},{"issue":"2","key":"1665_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1037\/pha0000509","volume":"30","author":"C Montiel","year":"2022","unstructured":"Montiel C, Newmark RL, Clark CT (2022) Perinatal use of lurasidone for the treatment of bipolar disorder. Exp Clin Psychopharmacol 30(2):249\u2013252. https:\/\/doi.org\/10.1037\/pha0000509","journal-title":"Exp Clin Psychopharmacol"},{"issue":"6","key":"1665_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1046\/j.1365-2125.2000.00298.x","volume":"50","author":"OV Olesen","year":"2000","unstructured":"Olesen OV, Linnet K (2000) Identification of the human cytochrome P450 isoforms mediating in vitro N -dealkylation of perphenazine. Br J Clin Pharmacol 50(6):563\u2013571. https:\/\/doi.org\/10.1046\/j.1365-2125.2000.00298.x","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1665_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/2045125314567115","volume":"5","author":"G Oriolo","year":"2015","unstructured":"Oriolo G, Barbosa L, Imaz ML, Garcia L, Borrego S, Parellada E (2015) Plasma levels of oral risperidone during enteral nutrition in a pregnant schizophrenic patient. Ther Adv Psychopharmacol 5(2):133\u2013137. https:\/\/doi.org\/10.1177\/2045125314567115","journal-title":"Ther Adv Psychopharmacol"},{"issue":"1","key":"1665_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"1665_CR41","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ n71. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"issue":"5","key":"1665_CR42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/00008571-199810000-00003","volume":"8","author":"LP Pan","year":"1998","unstructured":"Pan LP, De Vriendt C, Belpaire FM (1998) In-vitro characterization of the cytochrome P450 isoenzymes involved in the back oxidation and JV-dealkylation of reduced haloperidol. Pharmacogenet 8(5):383\u2013389. https:\/\/doi.org\/10.1097\/00008571-199810000-00003","journal-title":"Pharmacogenet"},{"key":"1665_CR43","doi-asserted-by":"publisher","unstructured":"Paulus W (2024) Antipsychotics in pregnancy \u2013 do we need therapeutic drug monitoring? https:\/\/doi.org\/10.1055\/s-0044-1779545. s-0044-1779545","DOI":"10.1055\/s-0044-1779545"},{"key":"1665_CR44","doi-asserted-by":"publisher","unstructured":"Peebles DM, Myatt L (eds) (2006) Inflammation and pregnancy, 0 edn. CRC. https:\/\/doi.org\/10.1201\/9780367800253","DOI":"10.1201\/9780367800253"},{"issue":"2","key":"1665_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1139\/jpn.0312","volume":"28","author":"TI Prior","year":"2003","unstructured":"Prior TI, Baker GB (2003) Interactions between the cytochrome P450 system and the second-generation antipsychotics. J Psychiatry Neuroscience: JPN 28(2):99\u2013112","journal-title":"J Psychiatry Neuroscience: JPN"},{"key":"1665_CR46","doi-asserted-by":"publisher","unstructured":"Seeman MV (2019) Antipsychotics during pregnancy: pros and cons. Open J Gynecol Obstet Res 58\u201364. https:\/\/doi.org\/10.36811\/ojgor.2019.110010","DOI":"10.36811\/ojgor.2019.110010"},{"issue":"11","key":"1665_CR47","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.4088\/JCP.09r05060gre","volume":"71","author":"A Sparshatt","year":"2010","unstructured":"Sparshatt A, Taylor D, Patel MX, Kapur S (2010) A systematic review of aripiprazole\u2014dose, plasma concentration, receptor occupancy, and response: implications for therapeutic drug monitoring. J Clin Psychiatry 71(11):1447\u20131456. https:\/\/doi.org\/10.4088\/JCP.09r05060gre","journal-title":"J Clin Psychiatry"},{"issue":"15","key":"1665_CR48","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1007\/s00213-014-3647-6","volume":"231","author":"A Stiegler","year":"2014","unstructured":"Stiegler A, Schaletzky R, Walter G, W\u00fcst R, Abele H, Goelz R, Farger G, Wiatr G, Fallgatter AJ, Batra A (2014) Olanzapine treatment during pregnancy and breastfeeding: a chance for women with psychotic illness? Psychopharmacology 231(15):3067\u20133069. https:\/\/doi.org\/10.1007\/s00213-014-3647-6","journal-title":"Psychopharmacology"},{"issue":"1","key":"1665_CR49","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/cpt.382","volume":"100","author":"Y Tasnif","year":"2016","unstructured":"Tasnif Y, Morado J, Hebert M (2016) Pregnancy-related pharmacokinetic changes. Clin Pharmacol Ther 100(1):53\u201362. https:\/\/doi.org\/10.1002\/cpt.382","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"1665_CR50","doi-asserted-by":"publisher","first-page":"410","DOI":"10.2174\/138920008784746373","volume":"9","author":"L Urichuk","year":"2008","unstructured":"Urichuk L, Prior T, Dursun S, Baker G (2008) Metabolism of atypical antipsychotics: involvement of cytochrome P450 enzymes and relevance for drug-drug interactions. Curr Drug Metab 9(5):410\u2013418. https:\/\/doi.org\/10.2174\/138920008784746373","journal-title":"Curr Drug Metab"},{"key":"1665_CR51","doi-asserted-by":"publisher","unstructured":"Viguera AC, Freeman MP, G\u00f3ez-Mogoll\u00f3n L, Sosinsky AZ, McElheny SA, Church TR, Young AV, Caplin PS, Chitayat D, Hern\u00e1ndez-D\u00edaz S, Cohen LS (2021) Reproductive safety of Second-Generation antipsychotics: updated data from the Massachusetts general hospital National pregnancy registry for atypical antipsychotics. J Clin Psychiatry 82(4). https:\/\/doi.org\/10.4088\/JCP.20m13745","DOI":"10.4088\/JCP.20m13745"},{"key":"1665_CR52","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.schres.2023.12.006","volume":"264","author":"G Wang","year":"2024","unstructured":"Wang G, Liu X, Huo Q, Lin S, Qiu Y, Wang F, Wang W (2024) Inflammation affects the pharmacokinetics of risperidone: does the dose need to be adjusted during the acute-phase reaction? Schizophr Res 264:122\u2013129. https:\/\/doi.org\/10.1016\/j.schres.2023.12.006","journal-title":"Schizophr Res"},{"issue":"3","key":"1665_CR53","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/cpt.770","volume":"103","author":"AA Westin","year":"2018","unstructured":"Westin AA, Brekke M, Molden E, Skogvoll E, Castberg I, Spigset O (2018) Treatment with antipsychotics in pregnancy: changes in drug disposition. Clin Pharmacol Ther 103(3):477\u2013484. https:\/\/doi.org\/10.1002\/cpt.770","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"1665_CR54","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/JCP.0000000000000171","volume":"34","author":"E Windhager","year":"2014","unstructured":"Windhager E, Kim S-W, Saria A, Zauner K, Amminger PG, Klier CM (2014) Perinatal use of aripiprazole: plasma levels, placental transfer, and child outcome in 3 new cases. J Clin Psychopharmacol 34(5):637\u2013641. https:\/\/doi.org\/10.1097\/JCP.0000000000000171","journal-title":"J Clin Psychopharmacol"},{"issue":"12","key":"1665_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15122727","volume":"15","author":"X Yang","year":"2023","unstructured":"Yang X, Grimstein M, Pressly M, Fletcher EP, Shord S, Leong R (2023) Utility of physiologically based pharmacokinetic modeling to investigate the impact of physiological changes of pregnancy and cancer on oncology drug pharmacokinetics. Pharmaceutics 15(12):2727. https:\/\/doi.org\/10.3390\/pharmaceutics15122727","journal-title":"Pharmaceutics"},{"issue":"5","key":"1665_CR56","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s40262-020-00962-3","volume":"60","author":"L Zheng","year":"2021","unstructured":"Zheng L, Tang S, Tang R, Xu M, Jiang X, Wang L (2021) Dose adjustment of quetiapine and aripiprazole for pregnant women using physiologically based pharmacokinetic modeling and simulation. Clin Pharmacokinet 60(5):623\u2013635. https:\/\/doi.org\/10.1007\/s40262-020-00962-3","journal-title":"Clin Pharmacokinet"},{"key":"1665_CR57","doi-asserted-by":"publisher","first-page":"793346","DOI":"10.3389\/fphar.2021.793346","volume":"12","author":"L Zheng","year":"2022","unstructured":"Zheng L, Yang H, Dallmann A, Jiang X, Wang L, Hu W (2022) Physiologically based pharmacokinetic modeling in pregnant women suggests minor decrease in maternal exposure to olanzapine. Front Pharmacol 12:793346. https:\/\/doi.org\/10.3389\/fphar.2021.793346","journal-title":"Front Pharmacol"}],"container-title":["Archives of Women's Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-025-01665-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00737-025-01665-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-025-01665-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:24:09Z","timestamp":1772000649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00737-025-01665-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1665"],"URL":"https:\/\/doi.org\/10.1007\/s00737-025-01665-z","relation":{},"ISSN":["1434-1816","1435-1102"],"issn-type":[{"value":"1434-1816","type":"print"},{"value":"1435-1102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors confirm that this systematic review did not require approval from a research ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors state that they have no known financial interests or personal relationships that could have influenced the work reported in this paper, including any affiliations with non-profit sectors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}